Pfizer Just Locked Next Growth Path: What Investors Should Know
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
Identify buffer targets, automate savings, and simulate scenarios to ensure your budget remains steady when unexpected costs arise.
19,194 articlesPfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
As the first quarter of 2026 unfolds, invivyd ivvd 2026 earnings take center stage for investors watching the biotech...
Teva is shifting from a debt-laden generic player to a branded-focused pharma with a stronger balance sheet. This piv...
A growing number of employers are layering cash balance features into 401(K) plans, allowing large annual deferrals f...
Midday trading shows the stock market today under pressure from higher yields and inflation fears. This guide explain...
As the Dow breaks above 50,000 in early 2026, investors revisit the ghost 36,000 milestone and debate whether old bet...
Air travel demand is rebounding and carriers are showing improved cash flow. This report flags the best airline stock...
Hyperliquid's HYPE defies a broad crypto slip, trading above $45 as Maxi Doge nears a $5 million presale milestone. T...
MBA Chief Bob Broeksmit calls for relief from cost-adding rules as mortgage rates remain elevated, urging targeted re...
Bitcoin has bounced and retraced before. This guide breaks down the real catalysts that could push BTC past $100k, wi...
An activist investor is pressing for board seats in a high-stakes proxy battle at Lululemon, highlighting questions a...
Solana is slipping as broader crypto markets pull back, with traders weighing key support levels and evolving ETF flo...